Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.1.25 (
triphosphatase
)
1,529
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The CDM (ced-5 of Caenorhabditis elegans, DOCK180 [downstream of Crk with molecular weight of 180 kDa] of humans, and myoblast city of Drosophila melanogaster) family of proteins has been shown to play a pivotal role in the integrin-mediated signaling pathway under the regulation of an adaptor molecule c-CT10-related kinase II (c-Crk-II) in adherent cells. Recently, hematopoietic cell-specific CDM protein
DOCK2
has been shown to be indispensable for lymphocyte migration. However, the regulatory mechanism for
DOCK2
is still unknown because
DOCK2
lacks a c-Crk-II binding consensus motif. In this study, we demonstrated that
DOCK2
bound to CrkL, which is present exclusively in hematopoietic cells both in vivo and in vitro, and we also found that 2 separate regions of
DOCK2
contributed to its binding to Src homology 3 (SH3) domain of CrkL. Colocalization of
DOCK2
with Crk-like (CrkL) and F-actin was shown by immunocytochemical analysis with the use of Jurkat cells. We also found that CrkL-induced activation of small guanine
triphosphatase
(GTPase) Rac1 was significantly inhibited by the
DOCK2
-dCS mutant in 293T cells. Furthermore, the association of
DOCK2
and Vav, the guanine-nucleotide exchanging factor (GEF) for Rac1, was demonstrated in Jurkat cells. Finally, the stable expression of
DOCK2
-dCS mutant in Jurkat cells was shown to reduce cell attachment. These data suggest the presence of a novel protein complex of CrkL,
DOCK2
, and Vav to regulate Rac1 in leukemia cell lines.
...
PMID:DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines. 1239 32
During chemotaxis, activation of the small guanosine
triphosphatase
Rac is spatially regulated to organize the extension of membrane protrusions in the direction of migration. In neutrophils, Rac activation is primarily mediated by
DOCK2
, an atypical guanine nucleotide exchange factor. Upon stimulation, we found that
DOCK2
rapidly translocated to the plasma membrane in a phosphatidylinositol 3,4,5-trisphosphate-dependent manner. However, subsequent accumulation of
DOCK2
at the leading edge required phospholipase D-mediated synthesis of phosphatidic acid, which stabilized
DOCK2
there by means of interaction with a polybasic amino acid cluster, resulting in increased local actin polymerization. When this interaction was blocked, neutrophils failed to form leading edges properly and exhibited defects in chemotaxis. Thus, intracellular
DOCK2
dynamics are sequentially regulated by distinct phospholipids to localize Rac activation during neutrophil chemotaxis.
...
PMID:Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. 1937 20